A new paradigm of survivorship care is needed that attempts to balance the patient’s total well-being against the often toxic treatment of the disease, suggests Deborah Korenstein, MD, Director of Clinical Effectiveness, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York City.
Linking physicians and patients is a major undertaking, but given the ubiquity of smartphone technology and the rise in app development, the healthcare industry is poised to leverage advances in communication and information exchange.
The American Society of Clinical Oncology (ASCO) maintains that a multidisciplinary team (MDT) is the cornerstone of quality care, yet despite incentives and interest, little is known about how teams affect cancer delivery.
San Francisco, CA—Sexual dysfunction is prevalent
in women with breast cancer, and is a consequence
of treatment that pre- and postmenopausal women
receive. As reported at the 2015 Breast Cancer Symposium,
however, the safety and efficacy of available treatments
remain understudied at this time.
Fertility and early menopause after cancer can pose
challenging emotional and medical issues for patients
and their clinicians. Survivors who become
infertile because of their cancer treatment are at an increased
risk for emotional distress and are often affected
by unresolved grief and depression, according to Ann H.
Partridge, MD, MPH, Medical Oncologist, Dana-Farber
Cancer Institute, Boston.
According to a recent assessment of bowel dysfunction–related needs, the hardships for colorectal cancer (CRC) survivors continue long after leaving the operating room, and survivors desire more information and strategies to help cope with unexpected changes to their bowel patterns, researchers said at the 2015 Gastrointestinal Cancers Symposium held in San Francisco, CA.